AIIMS Delhi To Screen Children For COVAXIN Trials Soon
New Delhi: India’s first indigenously developed Covid-19 vaccine--COVAXIN has been started screening for children, aged between 2 and 18.
The screening of children for the trial of the vaccine started at the AIIMS in Delhi on Monday.…